Equities

Jilin Province Huinan Changlong Bio-pharmacy Co Ltd

Jilin Province Huinan Changlong Bio-pharmacy Co Ltd

Actions
  • Price (EUR)0.141
  • Today's Change0.002 / 1.44%
  • Shares traded0.00
  • 1 Year change-16.57%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments6561,032262
Total Receivables, Net440585503
Total Inventory10313386
Prepaid expenses2.471838
Other current assets, total------
Total current assets1,2011,767890
Property, plant & equipment, net330360398
Goodwill, net6.256.256.25
Intangibles, net0.020.030.03
Long term investments753211776
Note receivable - long term------
Other long term assets------
Total assets2,3192,3732,072
LIABILITIES
Accounts payable716651
Accrued expenses300295233
Notes payable/short-term debt0.400.400
Current portion long-term debt/capital leases8.00--0.40
Other current liabilities, total346353287
Total current liabilities725715572
Total long term debt7200
Total debt800.400.40
Deferred income tax2.743.023.86
Minority interest------
Other liabilities, total384343
Total liabilities838761619
SHAREHOLDERS EQUITY
Common stock565656
Additional paid-in capital515151
Retained earnings (accumulated deficit)1,3731,5051,347
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity1,4801,6121,454
Total liabilities & shareholders' equity2,3192,3732,072
Total common shares outstanding560560560
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.